Activity Description Clause Samples

Activity Description. Where the Council makes a decision in relation to actions that may affect the Grey-headed Flying-fox and its habitat and the Council decides to apply the FFMP, it must: act in accordance with the FFMP; and impose the relevant mitigation standards described in the EPBC Act Flying-fox Guidelines. The Council and the Department will also pursue a range of actions at Batemans Bay, NSW, to support the conservation and recovery of the Grey‑headed Flying-fox, either independently or in collaboration. The Council must: deliver the following benefits by implementing the conservation management actions (however described) in the FFMP: enhanced habitat for biodiversity reduced impacts to flying-foxes regional conservation of flying-foxes and their ecosystem services reduced impacts to people living near a flying-fox camp improved public perception of flying-foxes consult with the Department on any proposed amendments to the Class of Actions identified in the FFMP and obtain the approval of the Minister before incorporating those amendments into the FFMP; undertake monitoring of the Grey-headed Flying-fox camp as set out in the FFMP; support quarterly surveys by NSW OEH of the Grey-headed Flying-fox for the National flying-fox monitoring program; and participate in research to improve knowledge of Grey-headed Flying-fox ecology. The Department will: finalise and publish the National Recovery Plan for the Grey-headed Flying-fox. Both Council and the Department must: develop and publish information to improve community understanding of, and capacity to manage the Grey-headed Flying-fox and its habitat. Council and the Department will pursue options for: supporting research into the ecology and management of the Grey-headed Flying-fox; and identifying and promoting the protection of key foraging and roosting habitats used by the Grey-headed Flying-fox. The Class of Actions is any action in relation to the management of Grey-headed Flying-fox and its Habitat: that is identified in the FFMP; and that is carried out in accordance with the mitigation standards described in Part 3 of the EPBC Act Flying-fox Guidelines. Note: If Council wishes to undertake actions that fall outside the Class of Actions described above, Council should consider the need to refer the actions to the Department for a decision under the EPBC Act. Pursuant to section 306A of the EPBC Act and subject to clause 4(a), the Minister declares that actions in the Class of Actions do not require approval und...

Activity Description. Purchase and demolish foreclosed houses that are blighted and are located in areas of low-to-moderate income as defined by the 2000 census. Once the houses are demolished, land bank, the land for future use to be defined within the 10 year timeframe provided by NSP program regulations/guidelines.

Activity Description. The Hirer warrants and agrees that the Activity is accurately described in the Agreement and has been accurately described to the Council during any pre-contractual correspondence and negotiations. Should the Hirer wish to change any details about the Activity, this will be subject to the Council’s prior consent and the Council may impose further charges, terms, and/or conditions before accepting any proposed changes.

Activity Description. Under this Agreement, <AGENCY> becomes the City’s Subrecipient for up to $<AMOUNT> of the City’s CDBG entitlement funds from the U.S. Department of Housing and Urban Development (HUD). As more fully described in Exhibit B, “Project Description and Project Budget,” attached hereto and incorporated as part of this Agreement, Subrecipient agrees to provide improvements at the <PROJECT-SITE>.

Activity Description. (not to exceed fifteen working days);

Activity Description. To determine the efficacy of the candidate second-generation vaginal microbicide PC-815, and to collect clinical data for supporting the New Drug Application, by carrying out three Phase 1 trials and a large multicenter Phase 2/3 trial. PC-815 combines the non-nucleoside reverse transcriptase inhibitor MIV-150 with Carraguard® in a proposed novel second-generation microbicide. Carraguard serves as the vehicle base for MIV-150 and as an active ingredient. The combination formulation has a number of highly attractive properties. The PC-815 clinical product development plan includes three Phase 1 trials, proceeding directly to a larger, multicenter Phase 2/3 trial. The first Phase 1 trial, to ensure vaginal safety, is to be conducted in early to mid-2005 under the direction of International Committee for Contraception Research member ▇▇▇▇▇▇ ▇▇▇▇▇▇ at the Asociación Dominicana Pro-Bienestar de la Familia (PROFAMILIA) clinic in the Dominican Republic. Assuming successful results, two additional, expanded Phase 1 trials, each with a particular primary endpoint to the protocol, will be conducted to further assess product safety. The second Phase 1 trial, also to be performed by PROFAMILIA, will be similar to the first, but include a pharmacokinetic component to measure the absorption of MIV-150 in the blood after vaginal use of PC-815. The third Phase 1 trial will evaluate lavages taken from HIV-positive women one hour after vaginal exposure to PC-815, to examine the effect of PC-815 on the survival of HIV in the vaginas of HIV-positive women post product use. This study will take place at the Setshaba Research Center, managed by the University of Limpopo/Medunsa Campus (formerly MEDUNSA), one of the sites for the Carraguard Phase 3 trial. Traditional Phase 2 trials focus on expanded safety and dose-finding. However, one of the unique challenges of conducting a clinical trial of a microbicide is that, unlike other prevention research, HIV infection has no surrogate endpoint, and it is doubtful that one will be identified. Therefore, because no true Phase 2 microbicide trial can be executed, a Phase 2/3 “proof of concept” study of PC-815 will be conducted to assess efficacy. While the expanded Phase 1 trials are in progress, a Phase 2/3 protocol will be developed and submitted for regulatory and ethical approval. This trial is expected to begin in late 2006. PC-815 will be compared to ▇▇▇▇▇▇▇▇▇▇ alone in this randomized, controlled, double-blind Phase 2/3 trial, p...

Activity Description. The description of the activity must include the following information: (1) What is the activity?; (2) Where would the activity be conducted? Describe the specific areas of the Refuge that will be used: habitat types and acres involved; key fish, wildlife, and plants that occur in or use that habitat; and the proportion of total Refuge acreage and the specific habitat type involved. Include a description of other areas that may be affected incidental to the specific activity, such as access to the destination area and storage of equipment; (3) When would the activity be conducted? Describe the time of year and day, and duration of the activity; (4) How would the activity be conducted? Describe the techniques to be used, types of equipment required, and number of people per given period. Include supporting uses and associated facilities, structures and improvements as appropriate; and (5) Why is this activity being proposed? Describe the reason for the activity and the need to conduct the use on the Refuge.

Activity Description. To conduct the nonclinical activities necessary to support the Phase 3 clinical trial of ▇▇▇▇▇▇▇▇▇▇ and to advance Carraguard through the development pipeline. ▇▇▇▇▇▇▇▇▇▇ is undergoing a Phase 3 clinical trial to determine its efficacy (see activity “Carraguard Clinical Development: Large-Scale Phase 3 Efficacy Trial”). Carraguard nonclinical development encompasses the efforts of the nonclinical microbicides team at the Center for Biomedical Research to support the trial and complete the necessary testing and development steps to bring Carraguard to market. All funds supporting Carraguard nonclinical projects come from USAID. The nonclinical team manages the manufacture of the study gels (Carraguard gel and methyl cellulose placebo gel), filling of the gels into single-use vaginal applicators, and packaging and shipping of the filled applicators to the trial sites in South Africa. Clean Chemical Sweden (CCS) executes these tasks under contract. Fifteen to 18 batches of each gel (approximately 65,000 applicators produced per batch) are needed for the trial. Three batches of each were produced beginning in December 2003 under the Population Council Program III cooperative agreement; through April 2006, 12 to 15 more batches of each will be produced under the Population Council Product Development cooperative agreement. The manufacturing process involves control testing each production batch to ensure that the gel is free of impurities, meets chemical and physical criteria, and is either biologically active (Carraguard) or inactive (methyl cellulose placebo gel). The nonclinical team will execute or manage these tests throughout production. Chemical identity is tested by the Population Council; impurity testing is contracted to The National Food Laboratory, Inc. (The NFL); evaluation of rheological parameters to CCS; activity, or strength, testing to ImQuest BioSciences, Inc.; and preservative efficacy testing to Sterilization Technical Services. Stability studies seek to measure how the quality of a formulation varies over time under the influence of various environmental factors. ▇▇▇▇▇▇▇▇▇▇ will undergo a five-year stability analysis: a five-year stability profile would provide major support for obtaining over-the-counter product labeling. Methyl cellulose placebo gel will undergo stability testing only through the end of the Phase 3 trial. Samples from the first three production batches of the gels have been stored by CCS since February 2004 in incubators...

Activity Description. This project has two complementary parts. The first utilizes data from a long-term village study to assess the impact of educational interventions on adolescent girls. These interventions include a food-for-education scheme for poor primary-school children, a female secondary school scholarship program, and a nonformal education program, all introduced on a national scale in the early 1990s. Making innovative use of previously collected data as well as a new wave of data collected in 2000, the project has generated a rich set of quantitative and qualitative information. Preliminary analysis suggests that these incentive schemes have indeed resulted in rapid increases in enrollment in primary and secondary schools and even some delay of marriage for girls. The 2000 survey assesses to what extent these effects have been sustained after six years of program implementation. The study also uses rich qualitative information available from nine years of data collection in the village. The survey data from 2000 is currently being entered and cleaned. The quantitative and qualitative data will then be integrated and analyzed in order to assess the impact of educational changes on village marriage patterns. The results will be presented at local dissemination activities and international conferences. Implementing Organizations: Population Council, Bangladesh Institute of Development Studies Activity Budget: $86,517 Core Contribution to Results Framework: IR 2.1 Activity Review The Reporting of Sensitive Behavior Among Adolescents: A Methodological Experiment in Kenya Country: Kenya Technical Monitor: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Period: June 1999–June 2002 Objective: To assess whether audio computer-assisted self-interviewing is feasible to use in a developing country and whether it produces more reliable data on sexual activity and related behaviors than traditional survey methods. Activity Description: While a considerable body of research exists on adolescent sexual activity in sub- Saharan Africa, it is the rare study that questions the reliability of the data collected. Yet published studies reveal not only strikingly different levels of premarital sex between boys and girls in virtually all countries, but also, more significantly, wide-ranging levels for each sex across countries that cannot be easily explained. Not only are the reported levels of sexual activity among females questionable, reported levels among males may also be problematic. Indeed, there has been some spe...